Cancer care in the United Kingdom: New solutions are needed

British Medical Journal

Volumn 327, Issue 7422, 2003, Pages 1044-1046

  Sikora, Karol ^a   Bosanquet, Nick ^b  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER; CANCER CARE; CANCER THERAPY; COST CONTROL; HEALTH CARE; HEALTH CARE DELIVERY; HEALTH CARE FINANCING; HEALTH CARE MANAGEMENT; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HUMAN; MEDICAL DECISION MAKING; MEDICAL TECHNOLOGY; NATIONAL HEALTH SERVICE; PRIORITY JOURNAL; REVIEW; UNITED KINGDOM;

EID: 0242351898     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.327.7422.1044     Document Type: Review

References (19)

1. Berrino F, Capocaccia R, Estève J, Gatta G, Micheli A, Hakulinen T, et al. Survival of cancer patients in Europe. The EUROCARE-2. Lyons: IARC, 1999. (Scientific publications No 151.)
2. Kunkler I. Managed clinical networks: a new paradigm for clinical medicine. J R Coll Physicians Lond 2000;34:230-3.
3. Department of Health. The NHS cancer plan. London: DoH, 2000.
4. Richards M. Investment in cancer in 2001/2002 and 2002/2003. London: Department of Health, 2003.
5. Robinson D, Bell C, Moller H, Basnett I. Effect of the UK government's 2-week target on waiting times for women with breast cancer in southeast England. Br J Cancer 2003;89:492-6.
6. Hutton J. Today programme, BBC Radio 4. 26 May 2003. http:// news.bbc.co.uk/1/hi/health/2937552.stm (accessed 18 Sep 2003).
7. Another NICE mess. Lancet Oncol 2002;3:385.
8. Patel R, Smith D, Reid I. One stop breast clinics - victims of their own success? A prospective audit of referrals to a specialist breast clinic. Eur J Surg Oncol 2000;26:452-4.
9. Cancer Services Collaborative. National monthly progress reports. www.modern.nhs.uk/cancer (accessed May 2003).
10. O'Rourke N, Edwards R. Lung cancer waiting times and tumour growth. Clin Oncol 2000;12:141-4.
11. Royal College of Pathologist. Submission to NICE on liquid based cytology for cervical screening. London: RCPath, 2002.
12. Department of Health. New opportunities fund. London: DoH, 1999.
13. Sikora K. Surrogate endpoints in cancer drug development. Drug Discovery Today 2002;7:951-6.
14. Department of Health. Delivering the NHS plan. Expenditure report. London: DoH, 2003.
15. UK Renal Registry. Report 2002. Bristol: UK Renal Registry, 2002.
16. Downer M. An interim determination of health gain from oral cancer and precancer screening. Community Dental Health 1998;15:72-6.
17. Brown M, Riley G, Potosky A. Obtaining long-term disease specific costs of care. Application to Medicare enrolees diagnosed with colorectal cancer. Med Care 1999;37:1249-59.
18. National Cancer Control Initiative. Optimising cancer care in Australia: a service with a patient focus. Melbourne: NCCI, 2003.
19. Kerr D. Redesigning cancer care. BMJ 2002;324:164-6. (Accepted 28 August 2003)